JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02320-07v1
82/10/4751    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Ruiz-Mateos, E.
Right arrow Articles by Marsh, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz-Mateos, E.
Right arrow Articles by Marsh, M.

 Previous Article  |  Next Article 

Journal of Virology, May 2008, p. 4751-4761, Vol. 82, No. 10
0022-538X/08/$08.00+0     doi:10.1128/JVI.02320-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

CD63 Is Not Required for Production of Infectious Human Immunodeficiency Virus Type 1 in Human Macrophages{triangledown}

Ezequiel Ruiz-Mateos,{dagger} Annegret Pelchen-Matthews, Magdalena Deneka, and Mark Marsh*

Cell Biology Unit, MRC Laboratory for Molecular Cell Biology and Department of Cell and Developmental Biology, University College London, Gower Street, London WC1E 6BT, United Kingdom

Received 26 October 2007/ Accepted 21 February 2008

During the assembly of human immunodeficiency virus type 1 (HIV-1) particles, the tetraspanin CD63 can be incorporated into the viral membrane. Indeed, cell surface tetraspanin microdomains that include CD63 have been proposed as sites for virus release. In addition, antibodies against CD63 can inhibit HIV infection of macrophages. In this cell type, HIV assembles into intracellularly sequestered plasma membrane domains that contain several other tetraspanins, including CD81, CD9, and CD53. CD63 is recruited to this domain following HIV infection. Together, these observations suggest that CD63 may have some function in the assembly of infectious virus particles and/or the infectivity of assembled virions. Here we have used RNA interference to knock down CD63 expression in monocyte-derived primary macrophages. We show that in the absence of CD63, HIV assembly is quantitatively comparable to that seen in CD63-expressing macrophages and that virus assembly occurs on compartments positive for CD81, CD9, and CD53. Moreover, the infectivity of macrophage-derived virus is unaffected by the loss of CD63. Together, our results indicate that at least in tissue culture, CD63 expression is not required for either the production or the infectivity of HIV-1.


* Corresponding author. Mailing address: MRC Laboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, United Kingdom. Phone: 44 20 7679 7807. Fax: 44 20 7679 7805. E-mail: m.marsh{at}ucl.ac.uk

{triangledown} Published ahead of print on 5 March 2008.

{dagger} Present address: Laboratorio de Inmunovirología. Servicio de Enfermedades Infecciosas, Hospitales Universitarios Virgen del Rocio, Avd. Manuel Siurot s/n, 41013 Sevilla, Spain.


Journal of Virology, May 2008, p. 4751-4761, Vol. 82, No. 10
0022-538X/08/$08.00+0     doi:10.1128/JVI.02320-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.